| Product NDC: | 63459-546 |
| Proprietary Name: | FENTORA |
| Non Proprietary Name: | fentanyl citrate |
| Active Ingredient(s): | 600 ug/1 & nbsp; fentanyl citrate |
| Administration Route(s): | BUCCAL; ORAL; TRANSMUCOSAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63459-546 |
| Labeler Name: | Cephalon, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021947 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060925 |
| Package NDC: | 63459-546-28 |
| Package Description: | 7 BLISTER PACK in 1 CARTON (63459-546-28) > 4 TABLET in 1 BLISTER PACK (63459-546-04) |
| NDC Code | 63459-546-28 |
| Proprietary Name | FENTORA |
| Package Description | 7 BLISTER PACK in 1 CARTON (63459-546-28) > 4 TABLET in 1 BLISTER PACK (63459-546-04) |
| Product NDC | 63459-546 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fentanyl citrate |
| Dosage Form Name | TABLET |
| Route Name | BUCCAL; ORAL; TRANSMUCOSAL |
| Start Marketing Date | 20060925 |
| Marketing Category Name | NDA |
| Labeler Name | Cephalon, Inc. |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 600 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |